BNTX vs. MDT: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at BNTX and MDT, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
BNTX trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, MDT is a standard domestic listing.
| Symbol | BNTX | MDT |
|---|---|---|
| Company Name | BioNTech SE | Medtronic plc |
| Country | Germany | Ireland |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Biotechnology | Health Care Equipment & Supplies |
| Market Capitalization | 26.76 billion USD | 119.44 billion USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | October 10, 2019 | May 2, 1973 |
| Security Type | ADR | Common Stock |
Historical Performance
This chart compares the performance of BNTX and MDT by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | BNTX | MDT |
|---|---|---|
| 5-Day Price Return | -1.24% | 1.35% |
| 13-Week Price Return | 13.80% | 7.19% |
| 26-Week Price Return | -9.35% | 1.11% |
| 52-Week Price Return | 23.76% | 9.90% |
| Month-to-Date Return | 3.53% | 3.30% |
| Year-to-Date Return | -2.33% | 16.70% |
| 10-Day Avg. Volume | 0.60M | 9.16M |
| 3-Month Avg. Volume | 0.99M | 7.63M |
| 3-Month Volatility | 45.29% | 19.48% |
| Beta | 1.53 | 0.79 |
Profitability
Return on Equity (TTM)
BNTX
-1.82%
Biotechnology Industry
- Max
- 77.14%
- Q3
- 10.76%
- Median
- -20.08%
- Q1
- -42.71%
- Min
- -119.20%
BNTX has a negative Return on Equity of -1.82%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.
MDT
9.62%
Health Care Equipment & Supplies Industry
- Max
- 34.53%
- Q3
- 19.38%
- Median
- 9.52%
- Q1
- 4.86%
- Min
- -7.58%
MDT’s Return on Equity of 9.62% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
BNTX
-24.18%
Biotechnology Industry
- Max
- 59.44%
- Q3
- 16.21%
- Median
- -11.49%
- Q1
- -167.42%
- Min
- -409.07%
BNTX has a negative Net Profit Margin of -24.18%, indicating the company is operating at a net loss as its expenses exceeded its revenues.
MDT
13.90%
Health Care Equipment & Supplies Industry
- Max
- 23.34%
- Q3
- 13.06%
- Median
- 9.53%
- Q1
- 5.96%
- Min
- -3.87%
A Net Profit Margin of 13.90% places MDT in the upper quartile for the Health Care Equipment & Supplies industry, signifying strong profitability and more effective cost management than most of its peers.
Operating Profit Margin (TTM)
BNTX
-47.73%
Biotechnology Industry
- Max
- 60.62%
- Q3
- 20.76%
- Median
- -12.41%
- Q1
- -181.14%
- Min
- -482.02%
BNTX has a negative Operating Profit Margin of -47.73%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.
MDT
17.76%
Health Care Equipment & Supplies Industry
- Max
- 29.44%
- Q3
- 17.80%
- Median
- 13.95%
- Q1
- 8.73%
- Min
- -3.56%
MDT’s Operating Profit Margin of 17.76% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | BNTX | MDT |
|---|---|---|
| Return on Equity (TTM) | -1.82% | 9.62% |
| Return on Assets (TTM) | -1.57% | 5.16% |
| Net Profit Margin (TTM) | -24.18% | 13.90% |
| Operating Profit Margin (TTM) | -47.73% | 17.76% |
| Gross Profit Margin (TTM) | 84.90% | 65.39% |
Financial Strength
Current Ratio (MRQ)
BNTX
8.61
Biotechnology Industry
- Max
- 19.31
- Q3
- 9.38
- Median
- 4.54
- Q1
- 2.45
- Min
- 0.76
BNTX’s Current Ratio of 8.61 aligns with the median group of the Biotechnology industry, indicating that its short-term liquidity is in line with its sector peers.
MDT
1.85
Health Care Equipment & Supplies Industry
- Max
- 4.90
- Q3
- 3.05
- Median
- 2.14
- Q1
- 1.49
- Min
- 0.86
MDT’s Current Ratio of 1.85 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
BNTX
0.01
Biotechnology Industry
- Max
- 1.35
- Q3
- 0.64
- Median
- 0.09
- Q1
- 0.00
- Min
- 0.00
BNTX’s Debt-to-Equity Ratio of 0.01 is typical for the Biotechnology industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
MDT
0.59
Health Care Equipment & Supplies Industry
- Max
- 1.49
- Q3
- 0.71
- Median
- 0.45
- Q1
- 0.14
- Min
- 0.00
MDT’s Debt-to-Equity Ratio of 0.59 is typical for the Health Care Equipment & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
BNTX
-1.43
Biotechnology Industry
- Max
- 72.37
- Q3
- 1.91
- Median
- -7.81
- Q1
- -63.90
- Min
- -153.80
BNTX has a negative Interest Coverage Ratio of -1.43. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.
MDT
10.20
Health Care Equipment & Supplies Industry
- Max
- 58.29
- Q3
- 25.56
- Median
- 9.06
- Q1
- 3.60
- Min
- -28.92
MDT’s Interest Coverage Ratio of 10.20 is positioned comfortably within the norm for the Health Care Equipment & Supplies industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | BNTX | MDT |
|---|---|---|
| Current Ratio (MRQ) | 8.61 | 1.85 |
| Quick Ratio (MRQ) | 8.48 | 1.42 |
| Debt-to-Equity Ratio (MRQ) | 0.01 | 0.59 |
| Interest Coverage Ratio (TTM) | -1.43 | 10.20 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
BNTX
0.00%
Biotechnology Industry
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
BNTX currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
MDT
3.01%
Health Care Equipment & Supplies Industry
- Max
- 4.05%
- Q3
- 1.76%
- Median
- 0.71%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 3.01%, MDT offers a more attractive income stream than most of its peers in the Health Care Equipment & Supplies industry, signaling a strong commitment to shareholder returns.
Dividend Payout Ratio (TTM)
BNTX
17.60%
Biotechnology Industry
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
At 17.60%, BNTX’s Dividend Payout Ratio is exceptionally high, exceeding the typical range for the Biotechnology industry. While this provides a significant return to shareholders, it may limit funds for reinvestment and could be difficult to sustain.
MDT
76.98%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 72.47%
- Median
- 27.49%
- Q1
- 0.00%
- Min
- 0.00%
MDT’s Dividend Payout Ratio of 76.98% is in the upper quartile for the Health Care Equipment & Supplies industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.
Dividend at a Glance
| Symbol | BNTX | MDT |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 3.01% |
| Dividend Payout Ratio (TTM) | 17.60% | 76.98% |
Valuation
Price-to-Earnings Ratio (TTM)
BNTX
--
Biotechnology Industry
- Max
- 60.14
- Q3
- 38.17
- Median
- 29.01
- Q1
- 15.12
- Min
- 0.00
P/E Ratio data for BNTX is currently unavailable.
MDT
25.55
Health Care Equipment & Supplies Industry
- Max
- 73.48
- Q3
- 51.69
- Median
- 34.31
- Q1
- 25.74
- Min
- 11.47
In the lower quartile for the Health Care Equipment & Supplies industry, MDT’s P/E Ratio of 25.55 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
Price-to-Sales Ratio (TTM)
BNTX
8.35
Biotechnology Industry
- Max
- 76.98
- Q3
- 36.53
- Median
- 9.49
- Q1
- 4.49
- Min
- 0.00
BNTX’s P/S Ratio of 8.35 aligns with the market consensus for the Biotechnology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
MDT
3.55
Health Care Equipment & Supplies Industry
- Max
- 9.53
- Q3
- 5.26
- Median
- 3.39
- Q1
- 2.13
- Min
- 0.00
MDT’s P/S Ratio of 3.55 aligns with the market consensus for the Health Care Equipment & Supplies industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
BNTX
1.19
Biotechnology Industry
- Max
- 20.53
- Q3
- 9.76
- Median
- 4.77
- Q1
- 2.49
- Min
- 0.59
BNTX’s P/B Ratio of 1.19 is in the lower quartile for the Biotechnology industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
MDT
2.25
Health Care Equipment & Supplies Industry
- Max
- 10.85
- Q3
- 5.98
- Median
- 3.48
- Q1
- 2.43
- Min
- 0.69
MDT’s P/B Ratio of 2.25 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
Valuation at a Glance
| Symbol | BNTX | MDT |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | -- | 25.55 |
| Price-to-Sales Ratio (TTM) | 8.35 | 3.55 |
| Price-to-Book Ratio (MRQ) | 1.19 | 2.25 |
| Price-to-Free Cash Flow Ratio (TTM) | 196.39 | 22.97 |